Plunkett Research Online: MEI Pharma Inc

MEI PHARMA INC (MEIP) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical deve.....


MEI PHARMA INC

Ticker: MEIP
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 858 792-6300
Fax:
Address: 9920 Pacific Heights Blvd
San Diego, CA 92130 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Justin FileCEO/CFO/Secretary
Frederick DriscollChairman of the Board/Director
See More
MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical deve.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture